BREAKOUT STOCK ALERT $ABUS - Arbutus Biopharma Corporation - Common Stock Initial Alert Price: $3.73 Potential Price: $4.50 Potential Gains: 21% Stop Loss Limit: $3.54 Looking for ABUS to bounce through the $4.10 Levels of Resistance and retest the $5.00 Levels once again, at least $4.50. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News...
...Another single stock opportunity that is worth building a bridge over; $ABUS (Arbutus Biopharma) an excellent and cheap shelter for the next chapter in covid flows. The beauty of choice! It is interesting as all covid vaccines will have to RNA IP .. this is a convincing driver. As well as creating a shelter, use the intimately linked highs to add and...
If Trades Above 3.40 Tgt 4.90-9 -12 SL 3.16
Arbutus Biopharma is an interesting stock. There's a lot to know about it. First of all they are trying to find a functional cure of HepB, this is called AB-729 and it is in the late stage 1 trials. They have announced results from a single dose study which were VERY positive and we are awaiting results from multi-dose part of the trial which should be announced...
ABUS is creating volatility contraction pattern
Fib level as of what i see now at .786 looks to be right here. its also where prior resistance may turn into support for the price. also the 200 sma has had time to catch up to the price of the stock and can be another indicator for the patient people on the sidelines that the chart has leveled off for now.
This stock has potential to retest $12.60.
Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-836, a capsid inhibitor that has the potential to inhibit HBV replication by preventing the assembly of...
Like how this chart is setting up with slight options activity Friday.
All, Amazing setup just need to make sure it holds. Buy in 1.26 (unless this breaks above) Should get some gains if everything goes well.
Bullish golden cross Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
Why do these bio's keep catching me. Hate bio's! but like to gamble. One might hold this a week or week and a half. Break out.